- Home
- KTTA vs KTOS Comparison
KTTA vs KTOS Comparison
Compare KTTA & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- KTOS
- Stock Information
- Founded
- KTTA 2020
- KTOS 1994
- Country
- KTTA United States
- KTOS United States
- Employees
- KTTA 4
- KTOS N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- KTOS Military/Government/Technical
- Sector
- KTTA Health Care
- KTOS Industrials
- Exchange
- KTTA Nasdaq
- KTOS Nasdaq
- Market Cap
- KTTA 5.5M
- KTOS 10.0B
- IPO Year
- KTTA 2021
- KTOS 1999
- Fundamental
- Price
- KTTA $0.71
- KTOS $79.21
- Analyst Decision
- KTTA
- KTOS Strong Buy
- Analyst Count
- KTTA 0
- KTOS 14
- Target Price
- KTTA N/A
- KTOS $56.79
- AVG Volume (30 Days)
- KTTA 201.4K
- KTOS 2.9M
- Earning Date
- KTTA 11-12-2025
- KTOS 11-06-2025
- Dividend Yield
- KTTA N/A
- KTOS N/A
- EPS Growth
- KTTA N/A
- KTOS 31.73
- EPS
- KTTA N/A
- KTOS 0.09
- Revenue
- KTTA N/A
- KTOS $1,213,100,000.00
- Revenue This Year
- KTTA N/A
- KTOS $17.66
- Revenue Next Year
- KTTA N/A
- KTOS $18.10
- P/E Ratio
- KTTA N/A
- KTOS $801.87
- Revenue Growth
- KTTA N/A
- KTOS 7.76
- 52 Week Low
- KTTA $0.65
- KTOS $22.17
- 52 Week High
- KTTA $7.50
- KTOS $76.72
- Technical
- Relative Strength Index (RSI)
- KTTA 41.76
- KTOS 78.25
- Support Level
- KTTA $0.74
- KTOS $61.40
- Resistance Level
- KTTA $0.81
- KTOS $65.29
- Average True Range (ATR)
- KTTA 0.06
- KTOS 3.42
- MACD
- KTTA -0.01
- KTOS 1.04
- Stochastic Oscillator
- KTTA 6.93
- KTOS 98.43
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.